SEC Form 4 · accession 0001179110-15-005434
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew J Greenfield
Officer — VP Healthcare Solutions
Period of report
Mar 23, 2015
Accepted (ET)
Mar 25, 2015 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par valueF5 | Mar 23, 2015 | A | 12,000 | $0.00 | A | 64,639 | D | |
| Common Stock, $.01 par value | Mar 23, 2015 | F | 2,901 | $61.43 | D | 61,738 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $13.57 | holding | — | — | — | Jun 1, 2007 | Jun 1, 2016 | Common Stock | 0 | 40,000 | D |
| Stock Option (right to buy)F1,F2 | $11.27 | holding | — | — | — | May 30, 2008 | May 30, 2017 | Common Stock | 0 | 10,000 | D |
| Stock Option (right to buy)F1,F2 | $13.80 | holding | — | — | — | May 23, 2009 | May 23, 2018 | Common Stock | 0 | 9,000 | D |
| Stock Option (right to buy)F3,F2 | $10.03 | holding | — | — | — | Jun 3, 2011 | Jun 3, 2020 | Common Stock | 0 | 25,000 | D |
| Stock Option (right to buy)F3,F2 | $22.44 | holding | — | — | — | May 22, 2013 | May 22, 2022 | Common Stock | 0 | 20,000 | D |
| Stock Option (right to buy)F3,F2 | $14.39 | holding | — | — | — | Feb 19, 2014 | Feb 19, 2023 | Common Stock | 0 | 20,000 | D |
| Stock Option (Right to Buy)F3,F2 | $23.15 | holding | — | — | — | May 14, 2014 | May 14, 2023 | Common Stock | 0 | 20,000 | D |
| Stock Option (right to buy)F3,F4 | $21.55 | holding | — | — | — | May 14, 2015 | May 14, 2024 | Common Stock | 0 | 15,000 | D |
Explanation of responses
- F1Grant to reporting person of option to buy shares of Common Stock under ABIOMED, Inc. 2000 Stock Incentive Plan.
- F2These options became exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- F3Grant to reporting person of option to buy shares of Common Stock under ABIOMED, Inc. 2008 Stock Incentive Plan.
- F4These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- F5These performance-based awards of restricted stock units were granted to this reporting person on May 14, 2014. One half of these restricted stock units vested on March 23, 2015 (into an equal number of shares of common stock) upon the issuer's achievement of a certain regulatory milestone with the remaining vesting on the first anniversary of such achievement.